Alnylam Pharmaceuticals Stock Target Price and Analyst Consensus

ALNY Stock  USD 241.76  0.01  0%   
The current analyst and expert consensus on Alnylam Pharmaceuticals is Buy with 11 buy recommendations. The current projected Alnylam Pharmaceuticals target price consensus is 298.97, with 32 analyst opinions. Alnylam Pharmaceuticals buy-or-sell recommendation module provides average expert sentiment on the projected Alnylam Pharmaceuticals target price to derive its highest and lowest estimates based on target price estimated volatility of 2.4541. Check out Macroaxis Advice on Alnylam Pharmaceuticals to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Alnylam Stock please use our How to Invest in Alnylam Pharmaceuticals guide.
Lowest Forecast
272.07
Highest Forecast
331.86
Target Price
298.97
At this time, Alnylam Pharmaceuticals' Gross Profit is fairly stable compared to the past year. Gross Profit Margin is likely to rise to 0.95 in 2025, whereas Pretax Profit Margin is likely to drop (0.08) in 2025. At this time, Alnylam Pharmaceuticals' Liabilities And Stockholders Equity is fairly stable compared to the past year. Non Current Liabilities Total is likely to rise to about 3.1 B in 2025, whereas Total Stockholder Equity is likely to drop slightly above 63.7 M in 2025.
  
It's important to approach Alnylam Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Alnylam Pharmaceuticals price targets

Alnylam Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Alnylam Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Alnylam Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Alnylam Pharmaceuticals' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Alnylam Pharmaceuticals Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Alnylam Pharmaceuticals is a key component of Alnylam Pharmaceuticals valuation and have some predictive power on the future returns of a Alnylam Pharmaceuticals.
Hype
Prediction
LowEstimatedHigh
239.28241.73244.18
Details
Intrinsic
Valuation
LowRealHigh
217.58273.96276.41
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.93-0.420.39
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Business Services Idea
Business Services
Invested few shares
Artificial Intelligence Idea
Artificial Intelligence
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested few shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Cash Cows Idea
Cash Cows
Invested few shares
SRI Sustainable Growth Idea
SRI Sustainable Growth
Invested over 40 shares
Apparel Idea
Apparel
Invested over 40 shares
Casinos Idea
Casinos
Sold over 90 shares
Utilities Idea
Utilities
Invested over 90 shares

Additional Tools for Alnylam Stock Analysis

When running Alnylam Pharmaceuticals' price analysis, check to measure Alnylam Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alnylam Pharmaceuticals is operating at the current time. Most of Alnylam Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Alnylam Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alnylam Pharmaceuticals' price. Additionally, you may evaluate how the addition of Alnylam Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.